A5092064469- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Cardiomyopathy and Myosin Studies
- Coronary Interventions and Diagnostics
- Aortic Disease and Treatment Approaches
- Hydrogen embrittlement and corrosion behaviors in metals
German Centre for Cardiovascular Research
2024
Background: Transcatheter aortic valve implantation (TAVI) for treatment of severe stenosis in patients with small annuli (≤23 mm) represent a technical challenge due to risk postoperative adverse hemodynamics terms elevated transvalvular pressure gradients and prosthesis-patient mismatch. Limited data exist regarding TAVI extra diameter ≤20.5 mm. The aim this study was analyze outcomes particular subset patients.
Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is a serious complication which associated with increased mortality. The RenalGuard system was developed to reduce the risk of AKI contrast media exposition by furosemide-induced diuresis matched isotonic intravenous hydration. aim this study examine effect on occurrence TAVI in patients chronic disease.
Background: In patients at high or prohibitive risk for redo mitral valve surgery, transcatheter replacement (TMVR) can be taken into consideration as a less invasive alternative. However, reports of long-term outcomes valve-in-ring (ViR) and valve-in-valve (ViV) procedures are scarce. We herein report 5-year following these procedures.